Matches in Wikidata for { <http://www.wikidata.org/entity/Q98605039> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q98605039 description "clinical trial" @default.
- Q98605039 description "ensayo clínico" @default.
- Q98605039 description "ensayu clínicu" @default.
- Q98605039 description "klinisch onderzoek" @default.
- Q98605039 description "клінічне випробування" @default.
- Q98605039 description "临床试验" @default.
- Q98605039 name "Camrelizumab With Apatinib as Neoadjuvant Therapy for Participants With Resectable Non-Small Cell Lung Cancer" @default.
- Q98605039 name "Camrelizumab With Apatinib as Neoadjuvant Therapy for Participants With Resectable Non-Small Cell Lung Cancer" @default.
- Q98605039 type Item @default.
- Q98605039 label "Camrelizumab With Apatinib as Neoadjuvant Therapy for Participants With Resectable Non-Small Cell Lung Cancer" @default.
- Q98605039 label "Camrelizumab With Apatinib as Neoadjuvant Therapy for Participants With Resectable Non-Small Cell Lung Cancer" @default.
- Q98605039 prefLabel "Camrelizumab With Apatinib as Neoadjuvant Therapy for Participants With Resectable Non-Small Cell Lung Cancer" @default.
- Q98605039 prefLabel "Camrelizumab With Apatinib as Neoadjuvant Therapy for Participants With Resectable Non-Small Cell Lung Cancer" @default.
- Q98605039 P1132 Q98605039-FEF34A46-5659-4BF9-8EBF-942EACC93409 @default.
- Q98605039 P1476 Q98605039-3DFBCC04-2FDD-4E5A-90AA-90F62A4BDFFB @default.
- Q98605039 P2899 Q98605039-62ECC9F5-4501-43CA-B80A-E377E00F3E1D @default.
- Q98605039 P3098 Q98605039-A689B70B-FEFA-43B1-99E2-73F16C613690 @default.
- Q98605039 P31 Q98605039-AB91BB3A-E485-4B8F-92F7-89141B25497A @default.
- Q98605039 P4135 Q98605039-CFAAD08E-C4F4-4195-A82D-ECD3ECA93E09 @default.
- Q98605039 P4844 Q98605039-1573697E-95D6-4C5B-84C0-E6E0D810D445 @default.
- Q98605039 P580 Q98605039-ECA5E794-FA92-4CE7-A762-7C16BBFADF33 @default.
- Q98605039 P582 Q98605039-67E36CF7-465F-4ADD-8EEE-261F817172CC @default.
- Q98605039 P6099 Q98605039-2C18D515-8D2D-4651-9A00-E23B2179DFCA @default.
- Q98605039 P8005 Q98605039-6A350049-EA28-4CA1-9C51-A97FF231864A @default.
- Q98605039 P8363 Q98605039-3B1EA5DE-3681-4AE3-93F6-3436D79796E6 @default.
- Q98605039 P1132 "+74" @default.
- Q98605039 P1476 "Efficacy and Safety of Camrelizumab (SHR-1210) With Apatinib as Neoadjuvant Therapy for Participants With Resectable Non-Small Cell Lung Cancer: a Single-Arm, Phase II Study" @default.
- Q98605039 P2899 "+18" @default.
- Q98605039 P3098 "NCT04506242" @default.
- Q98605039 P31 Q30612 @default.
- Q98605039 P4135 "+70" @default.
- Q98605039 P4844 Q27262801 @default.
- Q98605039 P580 "2020-08-15T00:00:00Z" @default.
- Q98605039 P582 "2021-12-30T00:00:00Z" @default.
- Q98605039 P6099 Q42824440 @default.
- Q98605039 P8005 Q76649614 @default.
- Q98605039 P8363 Q78089383 @default.